Innate CD8 T-cells as a potential predictive biomarker for deep molecular response in chronic myeloid leukemia patients
Abstract In chronic myeloid leukemia (CML), the role of immune effectors has been suggested in the achievement of a sustained deep molecular response (DMR) and treatment-free remission (TFR) after tyrosine kinase inhibitor (TKI) discontinuation. A contributory role of the distinct new innate CD8 T-c...
I tiakina i:
| Ngā kaituhi matua: | , , , , , , , , , , , , , , |
|---|---|
| Hōputu: | Artigo |
| Reo: | Inglês |
| I whakaputaina: |
Springer
2025-12-01
|
| Rangatū: | Cancer Immunology, Immunotherapy |
| Ngā marau: | |
| Urunga tuihono: | https://doi.org/10.1007/s00262-025-04256-0 |
| Ngā Tūtohu: |
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|
